Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

NCT06898307 is registered in ClinicalTrials.gov with University Hospital of Ferrara as lead sponsor.

NCT NCT06898307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06898307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART
Lead sponsor
University Hospital of Ferrara
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2017
Completion date
November 1, 2035
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrhythmias, cardiac disease, cardiology, genetic disease, genetic disorder